Actively Recruiting
A Study to Evaluate the Clinical Performance and Safety of UNICON Silicone Hydrogel Daily Disposable Soft Contact Lenses
Led by Unicon Optical Co. Ltd. · Updated on 2026-01-22
35
Participants Needed
2
Research Sites
40 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
13 weeks, open-label, daily disposable contact lens dispensing study.
CONDITIONS
Official Title
A Study to Evaluate the Clinical Performance and Safety of UNICON Silicone Hydrogel Daily Disposable Soft Contact Lenses
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult aged 18 years or older
- Currently wearing soft contact lenses successfully on both eyes at least 5 days per week and 6 hours per day within 3 months before screening
- Stopped wearing any contact lenses more than 7 days before screening
- Can wear contact lenses with power between -2.00D to -6.00D (in 0.25 D steps) in both eyes
- Astigmatism of 1.25D or less in both eyes
- Correctable to a visual acuity of 1.0 decimal (0.0 logMAR) or better in each eye
- Able to be successfully fitted with study lenses
- Willing and able to follow study instructions
- Able to read and sign the Informed Consent Form
You will not qualify if you...
- Currently pregnant women
- Women who are lactating or planning pregnancy at enrollment
- Use of systemic or ocular medications within 30 days before enrollment that contraindicate contact lens wear
- Any current or past ocular or systemic disease interfering with contact lens wear
- Orthokeratology treatment within 90 days before enrollment or planned during study
- History or planned ocular/refractive surgery
- Current or past herpetic keratitis in either eye
- Intolerance, allergy, or hypersensitivity to silicone hydrogel lenses or their components
- Clinical findings such as entropion, ectropion, chalazia, recurrent styes, glaucoma, pathological dry eye, recurrent corneal erosions, aphakia, or moderate or higher corneal distortion
- Employees of the ophthalmology department or clinic involved in the study
- Participation in any interventional clinical trial within 30 days before enrollment
- Biomicroscopy findings of Grade 3 or higher or corneal neovascularization Grade 2 or higher or corneal infiltrates
- History of contact lens-related corneal inflammatory or infectious event within 12 months before enrollment
- Anterior segment infection, inflammation, abnormality, or disease contraindicating contact lens wear
- Any participant deemed ineligible by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan, 807
Actively Recruiting
2
Linkou Chang Gung Memorial Hospital
Taoyuan, Taiwan, 333
Actively Recruiting
Research Team
N
Nick Liao
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here